Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
EJB-Egyptian Journal of Biochemistry and Molecular Biology [The]. 2012; 30 (2): 217-228
in English, Arabic | IMEMR | ID: emr-154381

ABSTRACT

The GC-box is an important transcriptional regulatory element present in the promoters of many mammalian genes, and is found in most, if not all, oxidative phosphorylation [OXPHOS] promoters. In the present study we examine the effects of three Spl family members [Sp2, Sp3, and Sp4] on the adenine nucleotide translocase 2, cytochrome cl, Fl-ATPase-subunit, and the mitochondria transcription factor [mtTFA] promoters in Drosophila SL2 cell line. Sp3, like Spl, strongly activates transcription all four promoters. SP4 stimulates, moderately, but Sp2 had no effect. In addition, Sp3 can, like Spl, inhibit transcription from the proximal promoter of the ANT2 gene through binding to the Cbox GC element. By contrast, Sp4 and Sp2 do not repress promoter activity. Furthermore, since Sp4 and Sp2 bind to the Cbox repression element on the ANT2 promoter, but do not repress transcription, inhibition of transcription cannot be explained by steric hindrance of pre-initiation complex assembly. These data suggest that different Spl family members differentially affect transcription from the OXPHOS promoters


Subject(s)
Sp2 Transcription Factor/genetics , Sp3 Transcription Factor/genetics
2.
Experimental & Molecular Medicine ; : 639-646, 2008.
Article in English | WPRIM | ID: wpr-59824

ABSTRACT

We previously reported that trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, induced DLC-1 mRNA expression and accumulated acetylated histones H3 and H4 associated with the DLC-1 promoter in DLC-1 non-expressing gastric cancer cells. In this study, we demonstrated the molecular mechanisms by which TSA induced the DLC-1 gene expression. Treatment of the gastric cancer cells with TSA activates the DLC-1 promoter activity through Sp1 sites located at -219 and -174 relative to the transcription start site. Electrophoretic mobility-shift assay (EMSA) revealed that Sp1 and Sp3 specifically interact with these Sp1 sites and showed that TSA did not change their binding activities. The ectopic expression of Sp1, but not Sp3, enhances the DLC-1 promoter responsiveness by TSA. Furthermore, the TSA-induced DLC-1 promoter activity was increased by p300 expression and reduced by knockdown of p300. These results demonstrated the requirement of specific Sp1 sites and dependence of Sp1 and p300 for TSA-mediated activation of DLC-1 promoter.


Subject(s)
Humans , Cell Line, Tumor , Electrophoretic Mobility Shift Assay , Histone Deacetylases/antagonists & inhibitors , Hydroxamic Acids/pharmacology , Promoter Regions, Genetic , Sp1 Transcription Factor/genetics , Sp3 Transcription Factor/genetics , Stomach Neoplasms/metabolism , Transcription, Genetic , Tumor Suppressor Proteins/biosynthesis , p300-CBP Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL